Weekly administration of brodalumab in hidradenitis suppurativa: an open‐label cohort study

British Journal of DermatologyVolume 184, Issue 2 p. 350-352 Research Letter Weekly administration of brodalumab in hidradenitis suppurativa: an open-label cohort study J.W. Frew, Corresponding Author jfrew@rockefeller.edu orcid.org/0000-0001-5042-3632 Laboratory of Investigative Dermatology, The Rockefeller University, New York, NY, USA Contribution: ​Investigation (lead), Methodology (equal), Visualization (lead), Writing - original draft (lead), Writing - review & editing (lead)Search for more papers by this authorK. Navrazhina, orcid.org/0000-0003-1405-2955 Laboratory of Investigative Dermatology, The Rockefeller University, New York, NY, USA Weill Cornell/Rockefeller/Sloan Kettering Tri-Institutional MD-PhD Program, New York, NY, USA Contribution: ​Investigation (supporting), Methodology (supporting), Validation (supporting), Writing - review & editing (supporting)Search for more papers by this authorM. Sullivan-Whalen, Laboratory of Investigative Dermatology, The Rockefeller University, New York, NY, USA Contribution: ​Investigation (supporting), Methodology (supporting), Writing - review & editing (supporting)Search for more papers by this authorP. Gilleaudeau, Laboratory of Investigative Dermatology, The Rockefeller University, New York, NY, USA Contribution: ​Investigation (supporting), Methodology (supporting), Writing - review & editing (supporting)Search for more papers by this authorS. Garcet, Laboratory of Investigative Dermatology, The Rockefeller University, New York, NY, USA Contribution: Data curation (equal), Software (equal), Writing - review & editing (supporting)Search for more papers by this authorJ.G. Krueger, Laboratory of Investigative Dermatology, The Rockefeller University, New York, NY, USA Contribution: Funding acquisition (lead), Resources (lead), Supervision (lead), Writing - review & editing (supporting)Search for more papers by this author J.W. Frew, Corresponding Author jfrew@rockefeller.edu orcid.org/0000-0001-5042-3632 Laboratory of Investigative Dermatology, The Rockefeller University, New York, NY, USA Contribution: ​Investigation (lead), Methodology (equal), Visualization (lead), Writing - original draft (lead), Writing - review & editing (lead)Search for more papers by this authorK. Navrazhina, orcid.org/0000-0003-1405-2955 Laboratory of Investigative Dermatology, The Rockefeller University, New York, NY, USA Weill Cornell/Rockefeller/Sloan Kettering Tri-Institutional MD-PhD Program, New York, NY, USA Contribution: ​Investigation (supporting), Methodology (supporting), Validation (supporting), Writing - review & editing (supporting)Search for more papers by this authorM. Sullivan-Whalen, Laboratory of Investigative Dermatology, The Rockefeller University, New York, NY, USA Contribution: ​Investigation (supporting), Methodology (supporting), Writing - review & editing (supporting)Search for more papers by this authorP. Gilleaudeau, Laboratory of Investigative Dermatology, The Rockefeller University, New York, NY, USA Contribution: ​Investigation (supporting), Methodology (supporting), Writing - review & editing (supporting)Search for more papers by this authorS. Garcet, Laboratory of Investigative Dermatology, The Rockefeller University, New York, NY, USA Contribution: Data curation (equal), Software (equal), Writing - review & editing (supporting)Search for more papers by this authorJ.G. Krueger, Laboratory of Investigative Dermatology, The Rockefeller University, New York, NY, USA Contribution: Funding acquisition (lead), Resources (lead), Supervision (lead), Writing - review & editing (supporting)Search for more papers by this author First published: 08 August 2020 https://doi.org/10.1111/bjd.19478Citations: 4 Funding sources: J.W.F. was supported in part by grant UL1 TR001866 from the National Center for Advancing Translational Sciences (NCATS), National Institutes of Health (NIH) Clinical and Translational Science Award (CTSA) programme. K.N. was supported by an MSTP grant from the National Institute of General Medical Sciences of the NIH under award number T32GM007739 to the Weill Cornell/Rockefeller/Sloan Kettering Tri-Institutional MD-PhD Program. Conflicts of interest: J.G.K. has received research support (grants paid to institution) from AbbVie, Amgen, BMS, Boehringer, EMD Serono, Innovaderm, Kineta, LEO Pharma, Novan, Novartis, Paraxel, Pfizer, Regeneron and Vitae; and personal fees from AbbVie, Acros, Allergan, Aurigne, BiogenIdec, Boehringer, Escalier, Janssen, Lilly, Novartis, Pfizer, Roche and Valeant. The other authors declare they have no relevant conflicts of interest. Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinked InRedditWechat No abstract is available for this article.Citing Literature Volume184, Issue2February 2021Pages 350-352 RelatedInformation